Samuel C. Bukantz

1.1k total citations
44 papers, 726 citations indexed

About

Samuel C. Bukantz is a scholar working on Physiology, Pediatrics, Perinatology and Child Health and Immunology and Allergy. According to data from OpenAlex, Samuel C. Bukantz has authored 44 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 7 papers in Pediatrics, Perinatology and Child Health and 7 papers in Immunology and Allergy. Recurrent topics in Samuel C. Bukantz's work include Asthma and respiratory diseases (10 papers), Pharmaceutical studies and practices (7 papers) and Allergic Rhinitis and Sensitization (6 papers). Samuel C. Bukantz is often cited by papers focused on Asthma and respiratory diseases (10 papers), Pharmaceutical studies and practices (7 papers) and Allergic Rhinitis and Sensitization (6 papers). Samuel C. Bukantz collaborates with scholars based in United States, Thailand and Brazil. Samuel C. Bukantz's co-authors include Richard F. Lockey, Demetrios S. Theodoropoulos, Roger W. Fox, Paul C. Turkeltaub, Kenneth Purcell, Lewis Bernstein, R.F. Lockey, Yoshio Tsuchiya, Joseph J. Krzanowski and Dean F. Martin and has published in prestigious journals such as JAMA, PEDIATRICS and Annals of the New York Academy of Sciences.

In The Last Decade

Samuel C. Bukantz

40 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel C. Bukantz United States 16 317 241 144 104 66 44 726
J Montoro Spain 22 778 2.5× 584 2.4× 340 2.4× 116 1.1× 74 1.1× 44 1.2k
Robert Puy Australia 13 1.5k 4.7× 1.3k 5.3× 645 4.5× 390 3.8× 72 1.1× 26 1.9k
Martha Cabrera Spain 13 242 0.8× 94 0.4× 67 0.5× 14 0.1× 28 0.4× 34 533
Zeynep Mısırlıgil Türkiye 23 631 2.0× 990 4.1× 305 2.1× 528 5.1× 385 5.8× 112 1.6k
L Rosenhall Sweden 28 579 1.8× 1.6k 6.5× 104 0.7× 1.3k 12.4× 30 0.5× 56 2.2k
G. H. Johnson United States 13 32 0.1× 83 0.3× 15 0.1× 54 0.5× 33 0.5× 35 452
James Potts United Kingdom 11 269 0.8× 318 1.3× 76 0.5× 156 1.5× 7 0.1× 35 647
Mary C. Edwards United Kingdom 9 67 0.2× 137 0.6× 11 0.1× 89 0.9× 16 0.2× 16 390
Carlos Nunes Portugal 7 227 0.7× 525 2.2× 28 0.2× 322 3.1× 8 0.1× 15 827
M Bartal Morocco 8 40 0.1× 121 0.5× 14 0.1× 109 1.0× 119 1.8× 21 412

Countries citing papers authored by Samuel C. Bukantz

Since Specialization
Citations

This map shows the geographic impact of Samuel C. Bukantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel C. Bukantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel C. Bukantz more than expected).

Fields of papers citing papers by Samuel C. Bukantz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel C. Bukantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel C. Bukantz. The network helps show where Samuel C. Bukantz may publish in the future.

Co-authorship network of co-authors of Samuel C. Bukantz

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel C. Bukantz. A scholar is included among the top collaborators of Samuel C. Bukantz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel C. Bukantz. Samuel C. Bukantz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
King, Monroe James, et al.. (2005). Serum total IgE and specific IgE to Dermatophagoides pteronyssinus, but not eosinophil cationic protein, are more likely to be elevated in elderly asthmatic patients.. PubMed. 25(5). 321–5. 25 indexed citations
2.
Bukantz, Samuel C., et al.. (2004). Adverse Effects and Fatalities Associated with Subcutaneous Allergen Immunotherapy. PubMed. 18. 736–753. 23 indexed citations
3.
Theodoropoulos, Demetrios S., et al.. (2002). Visceral sensitivity in gastroesophageal reflux.. Digestive Diseases and Sciences. 47(11). 2554–2564. 14 indexed citations
4.
Lockey, Richard F., et al.. (2001). Systemic reactions and fatalities associated with allergen immunotherapy. Annals of Allergy Asthma & Immunology. 87(1). 47–55. 105 indexed citations
5.
Lockey, R.F., et al.. (1992). Is there a role for cyclosporine in asthma?. Journal of Allergy and Clinical Immunology. 89(2). 629–636. 30 indexed citations
6.
Lockey, R.F., et al.. (1989). The Hymenoptera venom study II: Skin test results and safety of venom skin testing. Journal of Allergy and Clinical Immunology. 84(6). 967–974. 30 indexed citations
7.
Lockey, Richard F., et al.. (1988). The Hymenoptera venom study I, 1979–1982: Demographics and history-sting data. Journal of Allergy and Clinical Immunology. 82(3). 370–381. 86 indexed citations
8.
Polson, James B., Richard F. Lockey, Samuel C. Bukantz, et al.. (1988). Effects of ketotifen on the responsiveness of peripheral blood lymphocyte β-adrenergic receptors. International Journal of Immunopharmacology. 10(6). 657–663. 3 indexed citations
9.
Lockey, Richard F. & Samuel C. Bukantz. (1987). Principles of immunology and allergy. 11 indexed citations
10.
Fox, Roger W., Samuel C. Bukantz, & Richard F. Lockey. (1985). 249 Treatment of chronic idiopathic urticaria (CIU) with astemizole (A). Journal of Allergy and Clinical Immunology. 75(1). 167–167. 1 indexed citations
11.
Fox, Roger W., et al.. (1983). Theophylline kinetics in a geriatric group. Clinical Pharmacology & Therapeutics. 34(1). 60–67. 20 indexed citations
12.
Bukantz, Samuel C.. (1974). Adverse Drug Reactions. Hospital Practice. 9(1). 153–161. 7 indexed citations
13.
Braunwald, Eugene & Samuel C. Bukantz. (1971). Editorials. Hospital Practice. 6(5). 9–10. 2 indexed citations
14.
Bukantz, Samuel C.. (1968). The Stevens-Johnson syndrome. Disease-a-Month. 14(10). 1–36. 4 indexed citations
15.
Bukantz, Samuel C.. (1963). Residential Study and Treatment Center for Children with Intractable Asthma. JAMA. 185(2). 75–75. 4 indexed citations
16.
Bukantz, Samuel C., et al.. (1961). Growth rate of children with intractable asthma. Journal of Allergy. 32(5). 420–434. 39 indexed citations
17.
Bukantz, Samuel C. & M. Murray Peshkin. (1959). Institutional Treatment of Asthmatic Children. Pediatric Clinics of North America. 6(3). 755–773. 18 indexed citations
18.
Bukantz, Samuel C.. (1959). MANAGEMENT OF CHILDHOOD ALLERGIES WITH ANTI‐INFLAMMATORY STEROIDS. Annals of the New York Academy of Sciences. 82(4). 972–982. 6 indexed citations
19.
Frankel, Sam, et al.. (1954). Chemical and paper chromatographic investigation of ragweed pollen extract. Journal of Allergy. 25(1). 72–72. 1 indexed citations
20.
Bukantz, Samuel C., et al.. (1951). Fractionation of pollen extracts by chromatography. Journal of Allergy. 22(5). 437–449. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026